Xylazine
- Level
- Commodity
- Parent
- 51142000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51142034This classification denotes an alpha-adrenergic agonist with the molecular formula C12H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2KFG9TP5V8, chemically known as 5,6-dihydro-2-(2,6-xylidino)-4h-1,3-thiazine but generally known as xylazine, which bears US NIH Compound Identifier 5707. European Medicines Agency schedules Xylazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00120MIG. The term XYLAZINE is an International Non-Proprietary Name. XYLAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xylazine under HS 29349990 and SITC 51579. As of Q4 2014, XYLAZINE remains the US FDA Preferred Term for this commodity. Xylazine bears US NLM identifiers UMLS ID C0043366 and NCI Concept Code C75049. SMILES: CC1=C(C(=CC=C1)C)NC2=NCCCS2.
Same parent
Under 51142000 · 31Activities that produce or sell this
KBLI · 8Inherited from family 51140000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.